Organisation profile

Organisation profile

The Wellcome-Wolfson Institute for Experimental Medicine is committed to research excellence and is further enhancing the reputation of Queen’s University and Northern Ireland as a hub of innovation.

The Institute brings together world-class researchers, experts in the fields of immunology, microbiology, molecular and cell biology and clinical trials. Their collective focus is to understand why patients develop diseases and to make the discoveries which will lead to new therapies and improvements in their quality of life.

In particular, our research concentrates on the eye and circulatory system, inflammatory diseases of the lung and microbial (bacterial/viral) infections.

Collaboration is critical. We believe that our key strength is our approach to research – scientists and health professionals from different fields working together to tackle global health challenges from new perspectives. The Wellcome-Wolfson building has been designed to allow that to happen.

At the heart of everything we do is the goal of finding meaningful treatment for patients, making it work and having a local and global impact.

Keywords

  • R Medicine (General)
  • respiratory
  • vision
  • eyes
  • infection
  • immunity
  • cardiovascular
  • diabetes
  • lung
  • paedatrics
  • microbiome
  • heart disease
  • infectious diseases
  • copd
  • ms
  • virus
  • eye disease
  • amd

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):

  • SDG 2 - Zero Hunger
  • SDG 3 - Good Health and Well-being
  • SDG 4 - Quality Education
  • SDG 7 - Affordable and Clean Energy
  • SDG 10 - Reduced Inequalities
  • SDG 13 - Climate Action
  • SDG 14 - Life Below Water
  • SDG 16 - Peace, Justice and Strong Institutions
  • SDG 17 - Partnerships for the Goals

Fingerprint

Dive into the research topics where Wellcome Wolfson Institute for Experimental Medicine is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
  • 1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study

    Leavy, O. C., Russell, R. J., Harrison, E. M., Lone, N. I., Kerr, S., Docherty, A. B., Sheikh, A., Richardson, M., Elneima, O., Greening, N. J., Harris, V. C., Houchen-Wolloff, L., McAuley, H. J. C., Saunders, R. M., Sereno, M., Shikotra, A., Singapuri, A., Aul, R., Beirne, P. & Bolton, C. E. & 53 others, Brown, J. S., Choudhury, G., Diar Bakerly, N., Easom, N., Echevarria, C., Fuld, J., Hart, N., Hurst, J. R., Jones, M., Parekh, D., Pfeffer, P., Rahman, N. M., Rowland-Jones, S., Shah, A. M., Wootton, D. G., Jolley, C., Thompson, A. A. R., Chalder, T., Davies, M. J., De Soyza, A., Geddes, J. R., Greenhalf, W., Heller, S., Howard, L., Jacob, J., Jenkins, R. G., Lord, J. M., Man, W.D.-C., McCann, G. P., Neubauer, S., Openshaw, P. J. M., Porter, J., Rowland, M. J., Scott, J. T., Semple, M. G., Singh, S. J., Thomas, D., Toshner, M., Lewis, K., Heaney, L. G., Briggs, A., Zheng, B., Thorpe, M., Quint, J. K., Chalmers, J. D., Ho, L.-P., Horsley, A., Marks, M., Poinasamy, K., Raman, B., Wain, L. V., Brightling, C. E. & Evans, R. A., 30 Sept 2024, In: ERJ Open Research. 10, 5, 00474-2024.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    File
    2 Downloads (Pure)
  • A clinical score to predict recovery in end-stage kidney disease due to acute kidney injury

    Shah, S., Ng, J. H., Leonard, A. C., Harrison, K., Meganathan, K., Christianson, A. L. & Thakar, C. V., May 2024, In: Clinical Kidney Journal. 17, 5, sfae085.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    File
    28 Downloads (Pure)
  • A convergent evolutionary pathway attenuating cellulose production drives enhanced virulence of some bacteria

    Nhu, N. T. K., Rahman, M. A., Goh, K. G. K., Kim, S. J., Phan, M.-D., Peters, K. M., Alvarez-Fraga, L., Hancock, S. J., Ravi, C., Kidd, T. J., Sullivan, M. J., Irvine, K. M., Beatson, S. A., Sweet, M. J., Irwin, A. D., Vukovic, J., Ulett, G. C., Hasnain, S. Z. & Schembri, M. A., 21 Feb 2024, In: Nature Communications. 15, 1, 1441.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    File
    1 Citation (Scopus)
    35 Downloads (Pure)